Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
15310 studies found for:    Studies With Results
Show Display Options
Rank Status Study
21 Completed
Has Results
Fifty Two Week Extension Trial of Org 50081 (Esmirtazapine) in the Treatment of Insomnia (P05708)
Condition: Insomnia
Intervention: Drug: Org 50081
22 Terminated
Has Results
Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma;   Liver Cancer
Interventions: Drug: Sorafenib;   Radiation: Stereotactic Body Radiotherapy (SBRT)
23 Completed
Has Results
Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
Condition: Idiopathic Pulmonary Fibrosis
Intervention: Drug: Bosentan
24 Completed
Has Results
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
Condition: Melanoma
Interventions: Drug: Glycoprotein 100 (GP100): 209-217 (210M);   Drug: Interleukin-2 (IL-2);   Drug: Montanide ISA 51;   Drug: Melanoma antigen recognized by T-cells (MART)-1: 27-35;   Drug: 27-35 (27L): melanoma antigen recognized by T-cells (MART)-1;   Drug: melanoma antigen recognized by T-cells (MART)-1: 26-35(27L)
25 Active, not recruiting
Has Results
Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Acute Lymphoblastic Leukemia;   Lymphoma, Lymphoblastic
Interventions: Drug: Etoposide, cytarabine, vincristine, dexamethasone;   Drug: methotrexate, teniposide, PEG-asparaginase;   Drug: mitoxantrone, cyclophosphamide, mercaptopurine, vinblastine;   Drug: L-asparaginase, erwinia asparaginase;   Procedure: chemotherapy, intrathecal chemotherapy, steroid therapy;   Procedure: Hematopoietic Stem Cell Transplant;   Procedure: Natural Killer (NK) Cell Transplant
26 Completed
Has Results
The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease
Conditions: Hypertension;   Coronary Artery Disease
Interventions: Drug: Nebivolol;   Drug: Carvedilol
27 Completed
Has Results
United Kingdom User Evaluation, MiniMed Paradigm® X54 System
Condition: Diabetes Mellitus, Type 1
Intervention: Device: X54 insulin pump with low suspend feature
28 Completed
Has Results
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin phosphate;   Drug: Comparator: matching placebo
29 Completed
Has Results
Vatalanib in Treating Patients With Primary or Secondary Myelodysplastic Syndromes
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Intervention: Drug: vatalanib
30 Terminated
Has Results
Combined Patching-Atropine for Residual Amblyopia
Condition: Amblyopia
Interventions: Device: Patching;   Drug: Atropine
31 Completed
Has Results
A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment
Condition: Mild Cognitive Impairment
Interventions: Drug: Aricept (donepezil hydrochloride);   Drug: placebo
32 Completed
Has Results
A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer
Condition: Colorectal Cancer
Interventions: Drug: Gemcitabine;   Drug: avastin;   Drug: 5FU/folinic acid;   Drug: oxaliplatin
33 Active, not recruiting
Has Results
Implementing Evidence-Based Mental Health Practices in Primary Care
Condition: Alcohol Drinking
Interventions: Behavioral: brief alcohol intervention;   Behavioral: standard care
34 Completed
Has Results
Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure
Condition: Hypertension
Interventions: Drug: olmesartan medoxomil;   Drug: placebo
35 Completed
Has Results
Oxygen Monitoring of Patients After Surgery on the Hospital General Care Floor
Condition: Sleep Disordered Breathing
Intervention: Device: Oxygen Monitoring
36 Terminated
Has Results
Study of Low Level Laser Therapy and Tinnitus Relief
Condition: Tinnitus
Interventions: Device: Erchonia Hearing Lasers #1 & #2;   Device: Placebo Lasers
37 Completed
Has Results
A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants
Condition: Healthy
Interventions: Biological: MEDI-534, Cohort 1;   Other: Placebo, Cohort 1;   Biological: MEDI-534, Cohort 2;   Other: Placebo, Cohort 2;   Biological: MEDI-534, Cohort 3;   Other: Placebo, Cohort 3;   Biological: MEDI-534, Cohort 4;   Other: Placebo, Cohort 4;   Biological: MEDI-534, Cohort 5;   Other: Placebo, Cohort 5
38 Completed
Has Results
Sorafenib and Bortezomib Treatment for Relapsed or Refractory Multiple Myeloma Patients
Condition: Multiple Myeloma
Interventions: Drug: Bortezomib;   Drug: Sorafenib
39 Completed
Has Results
Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB
Condition: Hepatitis B Virus
Interventions: Drug: Telbivudine;   Drug: Tenofovir;   Drug: Telbivudine plus tenofovir
40 Completed
Has Results
Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer
Conditions: Biliary Tract Cancer;   Gallbladder Cancer;   Cancer Of The Extrahepatic Bile Duct;   Ampullary Carcinoma
Interventions: Drug: ZD6474, Vandetanib;   Drug: Gemcitabine;   Drug: Placebo matching ZD6474

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years